Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel disease

[1]  W. Curran,et al.  Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with Coronavirus Disease 2019-Related Pneumonia , 2020, International Journal of Radiation Oncology*Biology*Physics.

[2]  W. Curran,et al.  Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with COVID-19-Related Pneumonia , 2020, International Journal of Radiation Oncology*Biology*Physics.

[3]  F. Alongi,et al.  Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes. , 2020, The British journal of radiology.

[4]  F. Alongi,et al.  Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy , 2020, Radiation oncology.

[5]  J. Hou,et al.  Rates of Adverse IBD-Related Outcomes for Patients With IBD and Concomitant Prostate Cancer Treated With Radiation Therapy. , 2020, Inflammatory bowel diseases.

[6]  V. Khoo,et al.  The use of hydrogel spacer in men undergoing high-dose prostate cancer radiotherapy: results of a prospective phase 2 clinical trial , 2018, World Journal of Urology.

[7]  J. Wasiak,et al.  Prospective analysis of hydrogel spacer for patients with prostate cancer undergoing radiotherapy , 2018, BJU international.

[8]  I. Sobhani,et al.  [Radiation therapy in patients with inflammatory bowel disease. A review]. , 2018, Bulletin du cancer.

[9]  P. Karling,et al.  Radiation exposure in patients with inflammatory bowel disease and irritable bowel syndrome in the years 2001–2011 , 2017, Scandinavian journal of gastroenterology.

[10]  M. Fagundes,et al.  A comparison between hydrogel spacer and endorectal balloon: An analysis of intrafraction prostate motion during proton therapy , 2017, Journal of applied clinical medical physics.

[11]  C. Haie-meder,et al.  Inflammatory bowel diseases activity in patients undergoing pelvic radiation therapy. , 2017, Journal of gastrointestinal oncology.

[12]  T. Eade,et al.  SpaceOAR Hydrogel in Dose-escalated Prostate Cancer Radiotherapy: Rectal Dosimetry and Late Toxicity. , 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

[13]  R. Pollok,et al.  Diagnostic imaging and radiation exposure in inflammatory bowel disease. , 2016, World journal of gastroenterology.

[14]  Samir A. Shah,et al.  Risk factors for radiation exposure in newly diagnosed IBD patients , 2016, Abdominal Radiology.

[15]  A. Koong,et al.  Low Toxicity in Inflammatory Bowel Disease Patients Treated With Abdominal and Pelvic Radiation Therapy , 2015, American journal of clinical oncology.

[16]  D. Christie,et al.  Acute and Late Bowel Toxicity in Radiotherapy Patients with Inflammatory Bowel Disease: A Systematic Review. , 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

[17]  S. Cucchiara,et al.  Use of Imaging Techniques in Inflammatory Bowel Diseases That Minimize Radiation Exposure , 2015, Current Gastroenterology Reports.

[18]  E. Plimack,et al.  Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques. , 2015, Practical radiation oncology.

[19]  M. Kalady,et al.  Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: Risks and benefits , 2015, International Journal of Colorectal Disease.

[20]  Jason Wang,et al.  Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  K. Herfarth,et al.  A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes. , 2013, International journal of radiation oncology, biology, physics.

[22]  W. J. Morris,et al.  Toxicity after (125)I prostate brachytherapy in patients with inflammatory bowel disease. , 2013, Brachytherapy.

[23]  M. Zelefsky,et al.  Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. , 2012, International journal of radiation oncology, biology, physics.

[24]  Philippe Seksik,et al.  Epidemiology and natural history of inflammatory bowel diseases. , 2011, Gastroenterology.

[25]  R. C. Susil,et al.  Effects of prostate-rectum separation on rectal dose from external beam radiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[26]  S. Kazi,et al.  Effects of Perioperative Antiinflammatory and Immunomodulating Therapy on Surgical Wound Healing , 2005, Pharmacotherapy.

[27]  W. Sandborn,et al.  Epidemiology of inflammatory bowel disease. , 2002, Gastroenterology clinics of North America.

[28]  N. Kley,et al.  Anti-inflammatory effect of low-dose X-irradiation and the involvement of a TGF-β 1 -induced down-regulation of leukocyte/endothelial cell adhesion , 2002, International journal of radiation biology.

[29]  E. Kliewer,et al.  Cancer risk in patients with inflammatory bowel disease , 2001, Cancer.

[30]  A. Zietman,et al.  Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms. , 2000, International journal of radiation oncology, biology, physics.

[31]  K. Trott,et al.  Radiobiological mechanisms of anti-inflammatory radiotherapy. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[32]  J. Korzenik.  IBD: A Vascular Disorder? The Case for Heparin Therapy , 1997, Inflammatory bowel diseases.

[33]  M. Grisham.  Oxidants and free radicals in inflammatory bowel disease , 1994, The Lancet.

[34]  A. Ekbom,et al.  Epidemiology of inflammatory bowel disease , 1992, Current opinion in gastroenterology.

[35]  M. Hoffman,et al.  Early cervical cancer coexistent with idiopathic inflammatory bowel disease. , 1989, Southern medical journal.

[36]  N. Carr,et al.  Bowel Disease after Radiotherapy 1 , 1983, Journal of the Royal Society of Medicine.

[37]  G. Swanson,et al.  Long term clinical toxicity of radiation therapy in prostate cancer patients with Inflammatory Bowel Disease. , 2017, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[38]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[39]  Judy H Cho,et al.  Inflammatory bowel disease. , 2009, The New England journal of medicine.

[40]  R. Abrams,et al.  Acute and late radiotherapy toxicity in patients with inflammatory bowel disease. , 2001, International journal of radiation oncology, biology, physics.

[41]  R. Parshad,et al.  Deficient DNA repair in chronic ulcerative colitis. , 1997, Cancer detection and prevention.

[42]  K. Trott.  Therapeutic effects of low radiation doses. , 1994, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[43]  P. Schofield.  Bowel disease after radiotherapy. , 1984, Journal of the Royal Society of Medicine.